ResMed Inc

Healthcare · Medical Instruments & Supplies

218.90$ -1.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

ResMed Inc (RMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,464 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RMD
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	465	530	514	557	524	601	592	624	588	651	662	705	681	736	769	770	752	800	769	876	904	895	865	915	950	1,034	1,117	1,122	1,102	1,163	1,197	1,223	1,225	1,282	1,292	1,348	1,336	1,423	1,431	1,464	5,653
Cost of Revenue	196	221	214	233	218	251	247	261	245	267	270	287	276	309	320	321	313	338	322	385	398	391	373	392	409	454	499	505	502	493	515	519	507	531	525	528	515	538	540	602	2,196
Gross Profit	269	309	300	324	306	350	344	362	343	384	392	418	405	427	450	449	439	462	447	491	506	504	491	523	541	580	618	617	600	669	682	704	717	751	766	820	821	885	891	861	3,458
Research & Development	34	38	35	37	37	41	37	40	39	43	48	51	48	50	51	53	55	55	56	60	60	63	67	64	63	70	76	78	76	74	77	81	80	81	84	86	87	91	94	106	378
Selling, General & Administrative	129	139	138	148	144	152	148	157	147	162	165	172	167	171	172	165	159	169	160	181	177	185	182	195	194	212	228	241	223	222	230	242	239	242	245	265	259	278	286	296	1,120
Total Operating Expenses	175	212	192	196	193	204	208	216	199	227	235	297	234	230	232	226	222	241	224	249	244	256	257	267	265	300	317	342	311	394	307	323	330	334	340	366	374	387	391	413	1,565
Operating Income	94	97	107	127	113	146	136	147	144	157	157	121	171	198	218	223	217	222	223	242	262	249	234	255	276	280	301	275	289	275	375	381	387	417	426	455	447	498	500	449	1,893
Interest Expense	2.5	2.4	2.9	3.3	7.8	7.4	7.7	5.5	3.7	7.5	12	13	11	10	10.0	9.2	6.8	5.9	5.9	5.3	5.4	5.9	5.5	5.5	7.1	10	15	15	15	14	14	9.6	5.5	4.8	3.2	5.8	8.8	7.9	12	21	50
Pre-Tax Income	93	96	108	122	108	142	130	141	139	146	138	96	151	179	192	212	216	211	218	239	259	237	226	238	262	274	289	277	272	259	375	358	383	418	418	458	447	496	502	474	1,919
Income Tax Expense	17	19	20	20	22	132	20	31	33	22	33	27	30	18	29	34	37	31	296	44	55	36	47	43	51	49	57	47	53	51	75	65	72	74	53	78	98	104	104	91	396
Net Income	76	77	88	102	86	9.5	110	110	106	125	105	69	120	161	163	178	178	180	-78	195	204	202	179	195	210	225	233	230	219	209	300	292	311	345	365	380	349	393	399	383	1,523
EBITDA	123	126	144	153	142	175	177	186	175	199	199	151	215	234	264	267	267	278	271	290	312	293	283	289	313	334	357	341	341	377	444	362	443	479	470	532	503	566	584	493	2,146

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings